← Back to work
Works cited by this work
105 works
Work: Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Article20206 citationsABIAnti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin +20
Article20194 citationsABIThe paths and challenges of “off-the-shelf” CAR-T cell therapy: An overview of clinical trials
Vahid Moradi, Azadeh Omidkhoda, Naser Ahmadbeigi
Review article20234 citationsABICAR-T cell therapy for cancer: current challenges and future directions
Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7
Review article20254 citationsABINovel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh +2
Review article20253 citationsABIAxicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Frederick L. Locke, David B. Miklos, Caron A. Jacobson +28
Article20212 citationsABIKIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li, Rafet Başar, Guohui Wang +29
Article20222 citationsABINon-viral chimeric antigen receptor (CAR) T cells going viral
Hyatt Balke‐Want, Vimal Keerthi, Amaia Cadiñanos-Garai +6
Review article20232 citationsABITrogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape
You Zhai, Yicong Du, Guanzhang Li +9
Article20232 citationsABITrogocytosis-mediated immune evasion in the tumor microenvironment
Jeonghyun Kim, So Yeon Park, Jungseo Kim +6
Review article20252 citationsABINeutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
Hanke L. Matlung, Liane Babes, Xi Zhao +26
Article20182 citationsABIThe landscape of CAR-engineered innate immune cells for cancer immunotherapy
Ourania Tsahouridis, Max Xu, Feifei Song +2
Review article20252 citationsABI